D&O Ongoing Disclosure – Paul Dalla Lana

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Vital Healthcare Property Trust
Date this disclosure made:28-Aug-19
Date of last disclosure:
30-Aug-18
Director or senior manager giving disclosure
Full name(s):
Paul Dalla Lana
Name of listed issuer:
Vital Healthcare Property Trust
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director of NorthWest Healthcare
Properties Management Limited
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary units in Vital Healthcare
Property Trust
Nature of the affected relevant interest(s):
Paul Dalla Lana has a relevant interest
in ordinary units held by (a) NWI NZ
Management Company Limited
(beneficial owner), (b) NWI Healthcare
Properties LP (beneficial owner) and
(c) NorthWest NZ Finance Holdings
Limited (beneficial owner), as a result
of each of those entities being wholly
owned subsidiaries of NorthWest
Healthcare Properties REIT, of which
Paul Dalla Lana is the Chairman of the
Board of Trustees and holds an
approximate 18.7% interest in.
For that relevant interest-
Number held in class before acquisition or disposal:
110,823,292
Number held in class after acquisition or disposal:
112,743,175
Current registered holder(s):
NZGT Security Trustee Limited
(108,823,292) and Forsyth Barr
Custodians Limited (2,000,000)
Registered holder(s) once transfers are registered:
NZGT Security Trustee Limited
(108,823,292) and Forsyth Barr
Custodians Limited (3,919,883)
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A

Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: Two
Details of transactions requiring disclosure-
Date of transaction:22/08/2019 and 27/08/2019
Nature of transaction: Transaction one: On 22 August 2019,
4,919,883 ordinary units were issued
to NorthWest Healthcare Properties
Management Limited, the manager of
Vital Healthcare Property Trust, as
consideration for the manager's
incentive fee in accordance with
clauses 22.2(b) and 22.3(b) of the
Trust Deed.
Transaction two: On 27 August 2019,
NorthWest Healthcare Properties
Management Limited entered into an
agreement for the off-market sale of
3,000,000 units to funds associated
with or managed by Salt Funds
Management. The transfer of the units
is expected to be completed on 29
August 2019.
Name of any other party or parties to the transaction (if known):
Entities associated with Salt Funds
Management
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
The 4,919,883 units were issued as
consideration for NorthWest
Healthcare Properties Management
Limited's management incentive fee in
accordance with clauses 22.2(b) and
22.3(b) of the Trust Deed.
The consideration received for the
disposal of 3,000,000 units was
$2.5925 per unit.
Number of financial products to which the transaction related:
Transaction one: 4,919,883
Transaction two: (3,000,000)
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A

Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:ordinary units
Nature of relevant interest:
Paul Dalla Lana has a relevant interest
in:
(a) 102,684,228 ordinary units held by
NWI Healthcare Properties LP (as
beneficial owner);
(b) 3,919,883 ordinary units held by
NWI NZ Management Company
Limited (as beneficial owner); and
(c) 6,139,064 ordinary units held by
NorthWest NZ Finance Holdings
Limited (as beneficial owner).
For that relevant interest,-
Number held in class:
112,743,175
Current registered holder(s):
NZGT Security Trustee Limited
(108,823,292) and Forsyth Barr
Custodians Limited (3,919,883)
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative (if any):
N/A
The price's specified terms (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,-
N/A
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
28 August 2019
Name and title of authorised person:Bernard Crotty